Practical recommendations for the management of diabetes in patients with COVID-19

Stefan R Bornstein1, Francesco Rubino2, Kamlesh Khunti3

  • 1Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany; Paul Langerhans Institute Dresden of the Helmholtz Center Munich, University Hospital Carl Gustav Carus, Dresden, Germany; Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK; Department of Endocrinology and Diabetology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, Technische Universität Dresden, Dresden, Germany; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Insights

Diabetes significantly increases the risk of severe illness from coronavirus infections like COVID-19. This guidance offers practical management strategies for diabetes patients during the pandemic.

Area of Science:

  • Endocrinology
  • Infectious Diseases
  • Public Health

Background:

  • Diabetes is a critical comorbidity associated with severe outcomes in human pathogenic coronavirus infections, including SARS-CoV-2.
  • Individuals with diabetes face a higher risk of severe complications such as Adult Respiratory Distress Syndrome and multi-organ failure.
  • During the COVID-19 pandemic, 20-50% of patients globally had diabetes, highlighting a significant overlap.

Purpose of the Study:

  • To provide expert guidance and practical recommendations for managing diabetes during the COVID-19 pandemic.
  • To explore potential mechanistic links between novel coronavirus infection and diabetes.
  • To address the specific needs of diverse patient groups within the context of the pandemic.

Main Methods:

  • Convened an international panel of diabetes and endocrinology experts.
  • Synthesized current knowledge on coronavirus-diabetes interactions.
  • Developed evidence-based management strategies and recommendations.

Main Results:

  • Identified key mechanistic links between coronavirus infection and diabetes pathophysiology.
  • Formulated practical recommendations for diabetes management during the pandemic.
  • Highlighted differential management needs for various patient subgroups.

Conclusions:

  • Effective management of diabetes is crucial for mitigating severe outcomes in coronavirus infections.
  • Expert consensus provides essential guidance for healthcare providers.
  • Understanding patient-specific needs is vital for optimal pandemic response in diabetic populations.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
785
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
722
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.5K